SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

dc.contributor.authorKroon, H.
dc.contributor.authorTraeger, L.
dc.contributor.authorFitridge, R.
dc.contributor.authorSammour, T.
dc.contributor.authorMcVeay, C.
dc.contributor.authorHerath, M.
dc.contributor.authorCOVIDSurg Collaborative,
dc.contributor.authorGlobalSurg Collaborative,
dc.date.issued2022
dc.descriptionThis article is accompanied by an editorial by Marshall and Duggan. Anaesthesia 2022; 77: 3–6.
dc.description.abstractSARS-CoV-2 has been associated with an increased rate of venous thromboembolism in critically ill patients. Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri-operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism. We conducted a planned sub-study and analysis from an international, multicentre, prospective cohort study of elective and emergency patients undergoing surgery during October 2020. Patients from all surgical specialties were included. The primary outcome measure was venous thromboembolism (pulmonary embolism or deep vein thrombosis) within 30 days of surgery. SARS-CoV-2 diagnosis was defined as peri-operative (7 days before to 30 days after surgery); recent (1–6 weeks before surgery); previous (≥7 weeks before surgery); or none. Information on prophylaxis regimens or pre-operative anti-coagulation for baseline comorbidities was not available. Postoperative venous thromboembolism rate was 0.5% (666/123,591) in patients without SARS-CoV-2; 2.2% (50/2317) in patients with peri-operative SARSCoV- 2; 1.6% (15/953) in patients with recent SARS-CoV-2; and 1.0% (11/1148) in patients with previous SARSCoV- 2. After adjustment for confounding factors, patients with peri-operative (adjusted odds ratio 1.5 (95%CI 1.1–2.0)) and recent SARS-CoV-2 (1.9 (95%CI 1.2–3.3)) remained at higher risk of venous thromboembolism, with a borderline finding in previous SARS-CoV-2 (1.7 (95%CI 0.9–3.0)). Overall, venous thromboembolism was independently associated with 30-day mortality (5.4 (95%CI 4.3–6.7)). In patients with SARS-CoV-2, mortality without venous thromboembolism was 7.4% (319/4342) and with venous thromboembolism was 40.8% (31/76). Patients undergoing surgery with peri-operative or recent SARS-CoV-2 appear to be at increased risk of postoperative venous thromboembolism compared with patients with no history of SARS-CoV-2 infection. Optimal venous thromboembolism prophylaxis and treatment are unknown in this cohort of patients, and these data should be interpreted accordingly.
dc.description.statementofresponsibilityCOVIDSurg Collaborative and GlobalSurg Collaborative (Australia: Daniel Cox ... Hidde M Kroon ... Christina McVeay ... Matheesha Herath ... Luke Traeger ... Robert Fitridge ... Tarik Sammour ... et al. )
dc.identifier.citationAnaesthesia, 2022; 77(1):28-39
dc.identifier.doi10.1111/anae.15563
dc.identifier.issn0003-2409
dc.identifier.issn1365-2044
dc.identifier.orcidKroon, H. [0000-0002-8923-7527]
dc.identifier.orcidTraeger, L. [0000-0002-0327-7334]
dc.identifier.orcidFitridge, R. [0000-0001-6258-5997]
dc.identifier.orcidSammour, T. [0000-0002-4918-8871]
dc.identifier.orcidHerath, M. [0000-0003-2756-5864]
dc.identifier.urihttps://hdl.handle.net/2440/140022
dc.language.isoen
dc.publisherWiley
dc.rights© 2021 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists. This is an open access article under the terms of the CreativeCommons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
dc.source.urihttps://doi.org/10.1111/anae.15563
dc.subjectCOVIDSurg Collaborative; GlobalSurg Collaborative
dc.subject.meshHumans
dc.subject.meshPostoperative Complications
dc.subject.meshCohort Studies
dc.subject.meshProspective Studies
dc.subject.meshAge Distribution
dc.subject.meshSex Distribution
dc.subject.meshInternationality
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshMiddle Aged
dc.subject.meshFemale
dc.subject.meshMale
dc.subject.meshVenous Thromboembolism
dc.subject.meshYoung Adult
dc.subject.meshCOVID-19
dc.subject.meshSARS-CoV-2
dc.titleSARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_140022.pdf
Size:
601.72 KB
Format:
Adobe Portable Document Format
Description:
Published version